Incredible setup forming 👀

*This email contains promotional content

Markets took a hit yesterday.

The S&P 500 dropped 1.7%, the Nasdaq slid deeper into correction territory, and oil spiked hard as tensions in the Middle East continue to drive headlines.

I’ve been focusing on stocks that have (relatively) weathered the storm, and one that’s on my radar right now is an old-time favorite.

The stock ripped double-digits intraday all thirteen times I alerted it in 2025, and it picked the streak back up both times I alerted it last month.

When this stock starts moving… it tends to move fast.

The company did a $30 million raise at the start of this month, and the stock definitely took a hit. It has largely held its ground since March 3, though, even as the broader market has gotten shellacked.

And that’s where things get interesting…

Because typically a financing like that creates pressure. In this case, though, the raise was led by healthcare-dedicated investors and there were no warrants.That appears to have removed a major overhang.

On March 2, one analyst reiterated a Buy rating with a $14 price target.

Three days later, another analyst maintained a valuation north of $10 per share.

The company recently reported clinical data showing what it called “unprecedented efficacy” in its target indication, including disease control and survival metrics multiple times higher than standard of care.

So you’ve got:

A stock that pulled back after a capital raise…

A capital raise that reduces further dilution risk…

Analysts holding aggressive upside targets…

And a proven history of explosive intraday moves when it gets attention…

That kind of setup doesn’t show up often. I broke it all down on the page below.

👉 View Today’s Tactical Trade Idea 👈

This is one you’ll want on your radar before the bell.

To Your Success,

P.S. -⚡Daily Action in Market Masters Trading Room Starting at 9am ET  

(ALL are welcome)